Open AccessCase Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2
Author(s) -
Neyla Rivas,
M. Cecilia Espinoza,
Alejandra Lobán,
Odemaris Luque,
Julio Jurado,
Nicolás Henry-Hurtado,
Amador Goodridge
Publication year - 2020
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.20-0756
Subject(s) - tuberculosis , medicine , mycobacterium tuberculosis , concomitant , covid-19 , coinfection , respiratory system , immunology , aids related opportunistic infections , human immunodeficiency virus (hiv) , virology , sida , viral disease , disease , pathology , infectious disease (medical specialty)
COVID-19, designated as SARS-CoV-2, has caused millions of infections worldwide, including in patients with concomitant infections. Here, we report two unusual cases of patients with triple infections of SARS-CoV-2, Mycobacterium tuberculosis , and HIV. Both cases were confirmed through microbiological and immunological studies. The acute respiratory phase in both patients was treated with supplemental oxygen. Antituberculosis and antiretroviral therapies were started simultaneously. In 2 weeks, both patients demonstrated clinical improvement and recovery from COVID-19. Our findings suggest that even in cases of triple infection, clinical management together with respiratory therapy contributes to patient survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom